中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

基质金属蛋白酶-2、血管内皮生长因子、血小板活化因子对腹水性质的诊断价值

刘华

引用本文:
Citation:

基质金属蛋白酶-2、血管内皮生长因子、血小板活化因子对腹水性质的诊断价值

详细信息
  • 中图分类号: R446.6

  • [1]Elsharkawy AM, Oakley F, Mann DA.The role and regulation of he-patic stellate cell apoptosis in reversal of liver fibrosis[J].Apoptosis.2005, 10 (5) :927-39.
    [2]Liu HL, Li XH, Wang DY, et al.Matrix metalloproteinase-2and tissue inhibitor of metalloproteinase-1expression in fibrotic rat liver[J].World J Gastroenterology, 2000, 6:881-884.
    [3]Curran S, Murray GI.Matrix metalloproteinase:molecular aspects of their roles in tumor invasion and metastasis[J].Eur J Cancer, 2000, 36:1621-1630.
    [4]Waas ET, Lomme RM, DeGroot J, et al.Tissue levels of active ma-trix metalloproteinase-2and9in colorectal cancer[J].Br J Cancer, 2002, 86:1876-1883.
    [5]Kleiner DE, Stetler-Stevenson WG.Matrix metalloproteinases and metastasis[J].Cancer Chemother Pharmacol, 1999, 43 (Suppl) :S42-51.
    [6]Ji F, Wang WL, Yang ZL, et al.Study on the expression of matrix metallo proteinase-2mRNA in human gastric cancer[J].World J Gastroenterol, 1999, 5:455-457.
    [7] 蒋泽生, 高毅.基质金属蛋白酶的生物学特性及其在肿瘤浸润转移中的作用[J].世界华人消化杂志, 2000, 8:1403-1404.
    [8]Ellenrieder V, Alber B, Lacher U, et al.Role of MT-MMPs and MMP-2in pancreatic cancer progression[J].Int J Cancer, 2000, 85:14-20.
    [9]Huhtala P, ChowLT, Tryggvason K.Structure of the human typeⅣcollagenase gene[J].J Biol Chem, 1990, 265:1107-1108.
    [10]孙晓敏, 董卫国, 余保平, 等.恶性腹水基质金属蛋白酶活性分析[J].世界华人消化杂志, 2004, 12 (2) :376-378.
    [11]韩明子, 范玉晶, 王双双.基质金属蛋白酶-2, -9及铁蛋白对鉴别良恶性腹水的意义[J].世界华人消化杂志, 2005, 13 (7) :927-928.
    [12] 林红, 罗辉.血管内皮生长因子与恶性体腔积液[J].中华医学全科杂志, 2003, 11 (2) :41-44.
    [13]Chandra A, Angle N.Vascular endothelial growth factor stimulates a novel calcium-signaling pathway in vascular smooth muscle cells[J].Surgery, 2005, 138 (4) :780-7.
    [14]Nasciment I, Schaer R, Lemaire D, et al.Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malig-nant and nonmalignant ascites[J].APMIS, 2004, 112 (9) :585-7.
    [15]孙晓敏, 董卫国, 高礼层.血管内皮生长因子在恶性腹水诊断及形成中的作用[J].中国综合临床, 2004, 20 (4) :334-336.
    [16]Nagy JA, Masse EM, Herzberg KT, et al.Pathogenesis of ascites tumor growth:vascular perm eabifity factor, vascular hyperperme-ability, and ascites fluid accumulation[J].Cancer Res, 1995, 55 (2) :360-36.
    [17]Luo JC, Toyoda M, Shibuya M.Differential inhibition of fluid ac-cumulationan dtumor growt hintwo mouse ascites tumors by an antiva-seular endothelial growth factor/permeability factor neutralizing anti-body[J].Cancer Res, 1998, 58 (12) :2594-2600.
    [18]Mesiano S, Ferrara N, Jafe RB.Role of vascular endothelial growth factor in ovarian cancer:inhibition of ascites form ation by immunon-eutralization[J].American Journal of Pathology, 1998, 153 (4) :1249-1256.
    [19]Tandle A, Libutti SK.Antiangiogenic therapy:targeting vascular endothelial growth factor and its receptors[J].Clin Adv Hematol On-col, 2003, 1 (1) :41-8.
    [20]Wakelee HA, Schiller JH.Targeting angiogenesis with vascular en-dothelial growth factor receptor small-molecule inhibitors:novel a-gents with potential in lung cancer[J].Clin Lung Cancer, 2005, 7S1:S31-8.
    [21]Roudebush WE, Massey JB, Elsner CW, et al.The significance of platelet-activating factor and fertility in the male primate:a review[J].J Med Primatol, 2005, 34 (1) :20-4.
    [22]Yoo J, Sehhmdoree D, Neugardten J.Thromboxane medicates ther-enal hemodynamic effect of plateleth activating factor[J].J Pharma-col Exp Ther, 1990, 253 (3) :743-748.
    [23]Marrache AM, Gobeil F, Zhu T, et al.Intracellular signaling of lipid mediators via cognate nuclear G protein-coupled receptors[J].Endothelium, 2005, 12 (1-2) :63-72.
    [24] 曾宁心, 王家马龙.肝硬变患者血浆血小板活化因子检测及其内毒素血症的关系[J].中华医学杂志, 1992, 72 (3) :141-143.
    [25]Guarner F, Wallace JL, MacNaughton WK, et al.Endotoxin-in-duced ascites formation in the rat:partial mediation by platelet-ac-tivating factor[J].Hepatology, 1989, 10 (5) :788-94.
    [26]Fecchio D, Russo M, Sirois P, et al.Inhibition of Ehrlich ascites tumor in vivo by PAF-antagonists[J].Int J Immunopharmacol, 1990, 12 (1) :57-65.
  • 加载中
计量
  • 文章访问数:  1976
  • HTML全文浏览量:  1
  • PDF下载量:  797
  • 被引次数: 0
出版历程
  • 出版日期:  2008-06-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回